Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000014708
JPRN-UMIN000014708
Completed
Phase 4

Evaluation of Long-term efficacy, safety and predictors of Adalimumab in Crohn's disease: Japanese multicenter cohort study (ADJUST study) - Evaluation of Adalimumab in Crohn's disease

IBD Center, Sapporo Kosei General Hospital0 sites500 target enrollmentJuly 30, 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
IBD Center, Sapporo Kosei General Hospital
Enrollment
500
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 30, 2014
End Date
February 28, 2015
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
IBD Center, Sapporo Kosei General Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 1
Short-term and long-term efficacy and safety evaluation of acupoint catgut embedding in the simple obesity: a randomized controlled double-blind trial
ITMCTR2200005494The Fifth Affiliated Hospital of Southern Medical University
Active, not recruiting
Not Applicable
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects with Rheumatoid Arthritis.
EUCTR2009-016119-38-PLAmgen Inc220
Active, not recruiting
Not Applicable
Safety and Efficacy of AMG 827 in Subjects With RARheumatoid arthritisMedDRA version: 13.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Body processes [G] - Immune system processes [G12]
EUCTR2009-016119-38-GBAmgen Inc220
Active, not recruiting
Not Applicable
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects with Rheumatoid Arthritis.Rheumatoid arthritisMedDRA version: 12.1Level: LLTClassification code 10039073Term: Rheumatoid arthritis
EUCTR2009-016119-38-BGAmgen Inc220
Active, not recruiting
Not Applicable
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With PsoriasisModerate to severe plaque psoriasisMedDRA version: 17.0Level: PTClassification code 10037153Term: PsoriasisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
EUCTR2009-016163-12-DKAmgen Inc160